These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17007035)

  • 1. Activation of c-Yes in hepatocellular carcinoma: a preliminary study.
    Feng H; Masaki T; Nonomura T; Morishita A; Jian G; Nakai S; Deguchi A; Uchida N; Himoto T; Iwama H; Usuki H; Wakabayashi H; Izuishi K; Yoshiji H; Kurokohchi K; Kuriyama S
    World J Gastroenterol; 2006 Sep; 12(35):5743-5. PubMed ID: 17007035
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational analysis of SATB1 gene in hepatocellular carcinomas.
    Kim CJ; Lee GR; Shin JW; Jung SW; Park BR; Park NH
    APMIS; 2013 Oct; 121(10):1012-4. PubMed ID: 23278463
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma.
    Liu C; Ren YF; Dong J; Ke MY; Ma F; Monga SPS; Wu R; Lv Y; Zhang XF
    Cancer Lett; 2017 Dec; 410():20-31. PubMed ID: 28942012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
    Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: H-Prune gene regulatory networks.
    de Antonellis P
    EBioMedicine; 2019 Mar; 41():21-22. PubMed ID: 30772306
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation.
    Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF
    World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of insulin-like growth factor 1 in human primary liver cancer.
    Ikeda Y; Kajiyama K; Yamashita Y; Ikegami T; Uchiyama H; Soejima Y; Kawanaka H; Ikeda T; Morita M; Oki E; Saeki H; Suehiro T; Mimori K; Sugimachi K; Shirabe K; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Oct; 104(10):334-8. PubMed ID: 24511663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
    Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses".
    Avila MA; Lu KP
    Gastroenterology; 2007 Mar; 132(3):1180-3. PubMed ID: 17383439
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
    Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Autophagy in Hepatocellular Carcinoma.
    Lee YJ; Jang BK
    Int J Mol Sci; 2015 Nov; 16(11):26629-43. PubMed ID: 26561802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.
    Zou J; Li H; Huang Q; Liu X; Qi X; Wang Y; Lu L; Liu Z
    Tumour Biol; 2017 Oct; 39(10):1010428317719272. PubMed ID: 29025375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [β-catenin mutated hepatocarcinoma metabolic rewiring at the heart of their transformation].
    Senni N; Savall M; Bossard P
    Med Sci (Paris); 2018 Dec; 34(12):1029-1031. PubMed ID: 30623757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.